Found: 9
Select item for more details and to access through your institution.
HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 459, doi. 10.3390/cancers14020459
- By:
- Publication type:
- Article
Optimized Target Residence Time: Type I.
- Published in:
- Angewandte Chemie International Edition, 2017, v. 56, n. 19, p. 5363, doi. 10.1002/anie.201701185
- By:
- Publication type:
- Article
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14987-6
- By:
- Publication type:
- Article
Exploiting lipotoxicity for the treatment of liver cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling.
- Published in:
- PLoS Computational Biology, 2018, v. 14, n. 9, p. 1, doi. 10.1371/journal.pcbi.1006458
- By:
- Publication type:
- Article
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.
- Published in:
- Nature, 2011, v. 479, n. 7374, p. 547, doi. 10.1038/nature10599
- By:
- Publication type:
- Article
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.
- Published in:
- Nature Medicine, 2014, v. 20, n. 10, p. 1138, doi. 10.1038/nm.3679
- By:
- Publication type:
- Article
Optimierte Bindungsdauer am Zielenzym: Typ-I.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 19, p. 5448, doi. 10.1002/ange.201701185
- By:
- Publication type:
- Article
Nucleoporin Nup155 is part of the p53 network in liver cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10133-z
- By:
- Publication type:
- Article